Title : Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine - Hauber_2000_Clin.Ther_22_439 |
Author(s) : Hauber AB , Gnanasakthy A , Mauskopf JA |
Ref : Clin Ther , 22 :439 , 2000 |
Abstract :
OBJECTIVE: To estimate per-patient potential cost savings using rivastigmine in the treatment of Alzheimer's disease (AD) in Canada. BACKGROUND: In recent years, new members of a class of pharmaceuticals known as cholinesterase inhibitors have been introduced for the treatment of patients with AD. Two recent studies conducted in the United Kingdom and the United States estimated potential cost savings from the new cholinesterase inhibitor rivastigmine. The present study combined the disease-progression model used in those 2 studies with Canadian costs to estimate per-patient potential savings resulting from the treatment of AD in Canada. |
PubMedSearch : Hauber_2000_Clin.Ther_22_439 |
PubMedID: 10823365 |
Hauber AB, Gnanasakthy A, Mauskopf JA (2000)
Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine
Clin Ther
22 :439
Hauber AB, Gnanasakthy A, Mauskopf JA (2000)
Clin Ther
22 :439